FRMS CO., LTD(SZ:300049) Xin Lang Cai Jing·2025-11-12 01:26Core Insights - On November 11, Furuya Co., Ltd. experienced a slight decline of 0.27% in stock price, with a trading volume of 680 million yuan [1] - The company reported a financing buy-in of 140 million yuan and a financing repayment of 138 million yuan on the same day, resulting in a net financing buy of 1.14 million yuan [1] - As of November 11, the total margin balance for Furuya Co., Ltd. reached 1.38 billion yuan, indicating a high level of financing activity [1] Financing Overview - Furuya Co., Ltd. had a financing buy-in of 140 million yuan on November 11, with a current financing balance of 1.38 billion yuan, accounting for 7.04% of its market capitalization [1] - The financing balance is above the 90th percentile of the past year, indicating a high level of leverage [1] - In terms of securities lending, the company repaid 5,600 shares and sold 1,200 shares on November 11, with a total selling amount of 91,500 yuan [1] Company Performance - As of September 30, Furuya Co., Ltd. had 26,700 shareholders, an increase of 3.24% from the previous period, while the average number of circulating shares per shareholder decreased by 3.09% to 8,742 shares [2] - For the period from January to September 2025, the company achieved a revenue of 1.101 billion yuan, representing a year-on-year growth of 12.37%, and a net profit attributable to shareholders of 112 million yuan, up 9.69% year-on-year [2] Shareholder Structure - Since its A-share listing, Furuya Co., Ltd. has distributed a total of 246 million yuan in dividends, with 52.61 million yuan distributed over the past three years [3] - As of September 30, 2025, the top ten circulating shareholders included notable funds such as Huabao Zhongzheng Medical ETF and Ruiyuan Growth Value Mixed A, with some shareholders reducing their holdings [3] - New shareholders included Hong Kong Central Clearing Limited and Ping An Medical Health Mixed A, indicating a shift in the shareholder base [3]